Skip to main content
Fig. 3 | BMC Veterinary Research

Fig. 3

From: Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial

Fig. 3

Effect of metronidazole and rifaximin administration on clinical remission rates (box) and CIBDAI scores (columns and symbols) of dogs in both treatment groups. Columns in the graph represent mean ± SD, while symbols are individual CIBDAI scores of dogs in MET group and RIF group at D0 and at D21. **P < 0.001 D21 vs D0; ***P < 0.0001 D21 vs D0

Back to article page